158 related articles for article (PubMed ID: 19920850)
1. Oncogene and tumour suppressor: the two faces of SnoN.
Lamouille S; Derynck R
EMBO J; 2009 Nov; 28(22):3459-60. PubMed ID: 19920850
[TBL] [Abstract][Full Text] [Related]
2. SnoN functions as a tumour suppressor by inducing premature senescence.
Pan D; Zhu Q; Luo K
EMBO J; 2009 Nov; 28(22):3500-13. PubMed ID: 19745809
[TBL] [Abstract][Full Text] [Related]
3. Drosophila SnoN modulates growth and patterning by antagonizing TGF-beta signalling.
Ramel MC; Emery CM; Foulger R; Goberdhan DC; van den Heuvel M; Wilson C
Mech Dev; 2007 Apr; 124(4):304-17. PubMed ID: 17289352
[TBL] [Abstract][Full Text] [Related]
4. SnoN in mammalian development, function and diseases.
Jahchan NS; Luo K
Curr Opin Pharmacol; 2010 Dec; 10(6):670-5. PubMed ID: 20822955
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-β/SMAD Target gene SKIL is negatively regulated by the transcriptional cofactor complex SNON-SMAD4.
Tecalco-Cruz AC; Sosa-Garrocho M; Vázquez-Victorio G; Ortiz-García L; Domínguez-Hüttinger E; Macías-Silva M
J Biol Chem; 2012 Aug; 287(32):26764-76. PubMed ID: 22674574
[TBL] [Abstract][Full Text] [Related]
6. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
He J; Tegen SB; Krawitz AR; Martin GS; Luo K
J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
[TBL] [Abstract][Full Text] [Related]
7. Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells.
Zhu Q; Pearson-White S; Luo K
Mol Cell Biol; 2005 Dec; 25(24):10731-44. PubMed ID: 16314499
[TBL] [Abstract][Full Text] [Related]
8. Ski and SnoN: negative regulators of TGF-beta signaling.
Luo K
Curr Opin Genet Dev; 2004 Feb; 14(1):65-70. PubMed ID: 15108807
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling.
Yang J; Zhang X; Li Y; Liu Y
J Am Soc Nephrol; 2003 Dec; 14(12):3167-77. PubMed ID: 14638915
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles of SnoN in normal and cancerous human tissues support its tumor suppressor role in human cancer.
Jahchan NS; Ouyang G; Luo K
PLoS One; 2013; 8(2):e55794. PubMed ID: 23418461
[TBL] [Abstract][Full Text] [Related]
11. SnoN in TGF-beta signaling and cancer biology.
Pot I; Bonni S
Curr Mol Med; 2008 Jun; 8(4):319-28. PubMed ID: 18537639
[TBL] [Abstract][Full Text] [Related]
12. Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression.
Javelaud D; van Kempen L; Alexaki VI; Le Scolan E; Luo K; Mauviel A
Mol Cancer; 2011 Jan; 10(1):2. PubMed ID: 21211030
[TBL] [Abstract][Full Text] [Related]
13. SnoN is a cell type-specific mediator of transforming growth factor-beta responses.
Sarker KP; Wilson SM; Bonni S
J Biol Chem; 2005 Apr; 280(13):13037-46. PubMed ID: 15677458
[TBL] [Abstract][Full Text] [Related]
14. SnoN: bridging neurobiology and cancer biology.
Pot I; Ikeuchi Y; Bonni A; Bonni S
Curr Mol Med; 2010 Oct; 10(7):667-73. PubMed ID: 20712586
[TBL] [Abstract][Full Text] [Related]
15. [Ski and SnoN: antagonistic proteins of TGFbeta signaling].
Vignais ML
Bull Cancer; 2000 Feb; 87(2):135-7. PubMed ID: 10705283
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.
Krakowski AR; Laboureau J; Mauviel A; Bissell MJ; Luo K
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12437-42. PubMed ID: 16109768
[TBL] [Abstract][Full Text] [Related]
17. Dual role of SnoN in mammalian tumorigenesis.
Zhu Q; Krakowski AR; Dunham EE; Wang L; Bandyopadhyay A; Berdeaux R; Martin GS; Sun L; Luo K
Mol Cell Biol; 2007 Jan; 27(1):324-39. PubMed ID: 17074815
[TBL] [Abstract][Full Text] [Related]
18. SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.
Band AM; Laiho M
Cell Signal; 2012 Apr; 24(4):922-30. PubMed ID: 22227247
[TBL] [Abstract][Full Text] [Related]
19. [Promyelocytic leukaemia protein and defect in transforming growth factor-beta signal pathway in acute promyelocytic leukaemia].
Fuchs O; Provazníková D; Peslová G
Cas Lek Cesk; 2005; 144(2):90-4. PubMed ID: 15807293
[TBL] [Abstract][Full Text] [Related]
20. Actin-cytoskeleton polymerization differentially controls the stability of Ski and SnoN co-repressors in normal but not in transformed hepatocytes.
Caligaris C; Vázquez-Victorio G; Sosa-Garrocho M; Ríos-López DG; Marín-Hernández A; Macías-Silva M
Biochim Biophys Acta; 2015 Sep; 1850(9):1832-41. PubMed ID: 26002202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
